2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one
AssigneeAllergan, Inc.
InventorsKen Chow, Todd Heidelbaugh, Daniel Gil, Michael Garst, Larry Wheeler
Life of this patent
Estimating the term…
Abstract
A compound of the formula or a pharmaceutically acceptable salt thereof, is disclosed herein. Methods and compositions related thereto are also disclosed.
Claims16
A compound of the formula
- or a pharmaceutically acceptable salt thereof.
A compound comprising 2-((2-thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one, or a pharmaceutically acceptable salt thereof.
A method in accordance with claim 31 where the mammal is administered the composition for treating glaucoma.
A method in accordance with claim 31 where the mammal is administered the composition for treating neuropathies or neurodegenerative diseases.
A method in accordance with claim 31 where the mammal is administered the composition for treating muscle spasticity.
Dependencies are inferred from the claim text.